Cargando…

The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study

BACKGROUND: Lipocalin-2 is a novel adipokine that appears to play a role in the development of insulin resistance. Serum lipocalin-2 levels are elevated in obese patients. Obesity and insulin resistance are cardinal characteristics of the polycystic ovary syndrome (PCOS). However, there are limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panidis, Dimitrios, Tziomalos, Konstantinos, Koiou, Ekaterini, Kandaraki, Eleni A, Tsourdi, Elena, Delkos, Dimitrios, Kalaitzakis, Emmanuil, Katsikis, Ilias
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004902/ https://www.ncbi.nlm.nih.gov/pubmed/21143924 http://dx.doi.org/10.1186/1477-7827-8-151

Ejemplares similares

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
por: Papadakis, Georgios, et al.
Publicado: (2019)

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019)

Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
por: Psilopatis, Iason, et al.
Publicado: (2023)

MON-030 Intermediate Hyperglycemia and Type 2 Diabetes in Women with Polycystic Ovary Syndrome: Findings from Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2020)

Serum Levels of Gelatinase Associated Lipocalin as Indicator of the Inflammatory Status in Coronary Artery Disease
por: Kafkas, Nikolaos, et al.
Publicado: (2012)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
por: Farshchian, Fatemeh, et al.
Publicado: (2014)

Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
por: Kim, Jin Ju, et al.
Publicado: (2018)

Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
por: Paschou, Stavroula A., et al.
Publicado: (2015)

The Role of Statins in the Management of Patients Undergoing Coronary Artery Bypass Grafting
por: Siskos, Dimitrios, et al.
Publicado: (2018)

Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease
por: Kotsos, Dimitrios, et al.
Publicado: (2023)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome
por: Cao, Shunshun, et al.
Publicado: (2021)

Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Morbid Obesity Who Underwent Bariatric Surgery
por: Koukoulaki, Maria, et al.
Publicado: (2013)

Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice
por: Ande, Sudharsana Rao, et al.
Publicado: (2017)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014)

Relationship between serum cystatin C and polycystic ovary syndrome
por: Gozashti, Mohammad Hossein, et al.
Publicado: (2013)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
por: Günday, Özlem Kayacık, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
por: Hayes, M. Geoffrey, et al.
Publicado: (2015)

Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
por: Ilias, Ioannis, et al.
Publicado: (2021)

Ovulation induction techniques in women with polycystic ovary syndrome
por: Vyrides, Andreas A., et al.
Publicado: (2022)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome
por: Chen, Jie, et al.
Publicado: (2015)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome
por: Hu, Lili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gjrasj2sp5ph7qhltike60h63i